State Street Corp Celldex Therapeutics, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,979,751 shares of CLDX stock, worth $99.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,979,751

Previous 2,377,326 25.34%

Holding current value

$99.2 Million

Previous $94.3 Million 32.64%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $21.2 Million - $31.3 Million	602,425 Added 25.34%	2,979,751 $125 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $1.91 Million - $3.43 Million	84,475 Added 3.68%	2,377,326 $94.3 Million
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $11.1 Million - $16.3 Million	-434,455 Reduced 15.93%	2,292,851 $63.1 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $12.9 Million - $16.3 Million	424,781 Added 18.45%	2,727,306 $92.5 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $385,049 - $525,097	11,071 Added 0.48%	2,302,525 $82.8 Million

Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $24.4 Million - $39.9 Million	-880,124 Reduced 27.75%	2,291,454 $102 Million
Q3 2022 Nov 15, 2022	SELL	$22.7 - $37.57 $1.3 Million - $2.15 Million	-57,274 Reduced 1.77%	3,171,578 $89.2 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $11.2 Million - $20.4 Million	546,124 Added 20.36%	3,228,852 $87.1 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $8.7 Million - $12.4 Million	314,688 Added 13.29%	2,682,728 $91.4 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $18.2 Million - $28.7 Million	510,922 Added 27.51%	2,368,040 $91.5 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $6.86 Million - $13.3 Million	-237,100 Reduced 11.32%	1,857,118 $100 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $4.5 Million - $7.68 Million	217,241 Added 11.57%	2,094,218 $70 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $1.08 Million - $2 Million	66,717 Added 3.69%	1,876,977 $38.7 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $26.8 Million - $40.6 Million	1,784,873 Added 7030.66%	1,810,260 $31.7 Million
Q3 2020 Nov 10, 2020	BUY	$9.65 - $15.19 $244,984 - $385,628	25,387 New	25,387 $376,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

61.2M

Call Options Held

291K

Put Options Held

246K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.56B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Celldex Therapeutics, Inc. Transaction History